Therapy for Rare Cancers receives FDA approval following trials at Penn’s Abramson Cancer
Credit: Penn Medicine PHILADELPHIA - The U.S. Food and Drug Administration (FDA) has approved the first ever non-surgical treatment for the rare neuroendocrine cancers pheochromocytoma...





